Brinker Capital Inc. Grows Position in Varian Medical Systems, Inc. (NYSE:VAR)

Brinker Capital Inc. raised its holdings in shares of Varian Medical Systems, Inc. (NYSE:VAR) by 20.2% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 19,633 shares of the medical equipment provider’s stock after buying an additional 3,304 shares during the quarter. Brinker Capital Inc.’s holdings in Varian Medical Systems were worth $2,338,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the company. Crossmark Global Holdings Inc. grew its holdings in shares of Varian Medical Systems by 1.2% in the second quarter. Crossmark Global Holdings Inc. now owns 7,589 shares of the medical equipment provider’s stock valued at $1,033,000 after purchasing an additional 89 shares during the period. Sepio Capital LLC grew its holdings in shares of Varian Medical Systems by 0.4% in the second quarter. Sepio Capital LLC now owns 21,692 shares of the medical equipment provider’s stock valued at $2,953,000 after purchasing an additional 89 shares during the period. Berman Capital Advisors LLC grew its holdings in shares of Varian Medical Systems by 16.3% in the second quarter. Berman Capital Advisors LLC now owns 656 shares of the medical equipment provider’s stock valued at $89,000 after purchasing an additional 92 shares during the period. Whittier Trust Co. grew its holdings in shares of Varian Medical Systems by 0.8% in the third quarter. Whittier Trust Co. now owns 12,303 shares of the medical equipment provider’s stock valued at $1,465,000 after purchasing an additional 93 shares during the period. Finally, Zions Bancorporation N.A. grew its holdings in shares of Varian Medical Systems by 5.7% in the second quarter. Zions Bancorporation N.A. now owns 1,787 shares of the medical equipment provider’s stock valued at $243,000 after purchasing an additional 96 shares during the period. 91.32% of the stock is owned by institutional investors and hedge funds.

In other Varian Medical Systems news, SVP John W. Kuo sold 465 shares of the company’s stock in a transaction dated Monday, September 16th. The shares were sold at an average price of $116.30, for a total value of $54,079.50. Following the transaction, the senior vice president now owns 35,411 shares of the company’s stock, valued at $4,118,299.30. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders sold 1,395 shares of company stock worth $158,388 in the last ninety days. 0.74% of the stock is currently owned by corporate insiders.

NYSE VAR opened at $114.68 on Wednesday. The firm’s 50-day moving average is $113.84 and its two-hundred day moving average is $124.53. Varian Medical Systems, Inc. has a 12 month low of $101.42 and a 12 month high of $142.50. The stock has a market capitalization of $10.47 billion, a P/E ratio of 25.95, a PEG ratio of 2.74 and a beta of 0.87.

Varian Medical Systems (NYSE:VAR) last posted its earnings results on Wednesday, July 24th. The medical equipment provider reported $1.32 EPS for the quarter, beating the Zacks’ consensus estimate of $1.14 by $0.18. Varian Medical Systems had a net margin of 10.75% and a return on equity of 24.91%. The company had revenue of $825.80 million for the quarter, compared to analysts’ expectations of $762.29 million. During the same quarter in the prior year, the company posted $1.04 earnings per share. Varian Medical Systems’s revenue for the quarter was up 16.5% compared to the same quarter last year. On average, equities research analysts anticipate that Varian Medical Systems, Inc. will post 4.63 EPS for the current fiscal year.

A number of brokerages recently issued reports on VAR. ValuEngine lowered shares of Varian Medical Systems from a “buy” rating to a “hold” rating in a report on Tuesday, August 20th. TheStreet cut shares of Varian Medical Systems from a “b” rating to a “c+” rating in a research report on Monday, August 5th. Robert W. Baird set a $158.00 target price on shares of Varian Medical Systems and gave the company a “buy” rating in a research report on Friday, July 26th. BTIG Research raised shares of Varian Medical Systems from a “neutral” rating to a “buy” rating and set a $130.00 target price on the stock in a research report on Monday, October 14th. Finally, Zacks Investment Research cut shares of Varian Medical Systems from a “strong-buy” rating to a “hold” rating and set a $139.00 target price on the stock. in a research report on Saturday, July 27th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and seven have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $140.50.

About Varian Medical Systems

Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Proton Solutions. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as related quality assurance equipment.

See Also: Stop Order

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.